Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman
NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that it has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman has a beneficial interest, purchased 29,318 common shares priced between $0.78 and $0.81 per share.
The acquisition takes Mr Cerrone's interests from 37.70% to 37.72%.
About Tiziana Life Sciences
For further inquiries:
Tiziana Life Sciences Ltd